TruthArchive.ai - Related Video Feed

We received four Pfizer vaccines, and the one we sequenced is different from any previously analyzed. This may be an earlier version that Pfizer modified later. The vaccine contains a common plasmid used in coronavirus research, which raises questions about its origin. While Pfizer is the likely source, it's possible it leaked from a lab. We found similarities and differences in the components of the vaccines. The contamination hypothesis is unlikely since the plasmids have never been handled in our labs, and formalin fixation prevents spike protein production. Pfizer could have multiple undisclosed plasmids, which would be concerning, especially since we found one in a colon cancer sample that produces spike protein at high levels, indicating it could be replication competent and potentially transmissible. Transmissible cancer is a significant issue.

A recent paper suggests that COVID vaccines may meet the multi-hit hypothesis for cancer. According to the paper, the vaccines affect the p53 and BRCA tumor suppressor systems, impair DNA repair, and contain DNA fragments with cancer-promoting properties. The presence of SV40, a known cancer promoter, in the vaccines further supports this hypothesis. While it is important to note that this applies to some individuals, it suggests a potential link between the vaccines and cancer development.

Speaker 0 asserts that packaged DNA fragments have been found en masse as vaccine contaminants. Once they reach the nucleus, short DNA sequences have an increased propensity to insert into chromosomal DNA. The possible consequences are unending, including disruption of the exquisitely tuned network that controls cell division and differentiation, which can lead to cancer and developmental defects. Mutations in sperm and fertilized egg cells could render altered traits inheritable. Speaker 0 further states that cost effective procedures to reliably separate mass produced RNA from plasmids do not exist, and therefore contamination of RNA vaccines with plasmid DNA must be expected to be the rule and not the exception. Whoever propagates RNA vaccines as being safe and effective, whoever claims that nothing can happen to your genome is either incredibly ignorant or endlessly evil. That person is turning his back on the horror scenario that is unfolding in front of our very eyes. Fellow citizens and physicians of the world are urged to turn away from the perpetrators of this monstrous crime against humanity. Speaker 0 concludes with admonitions to do this to save yourself, your descendants, and to rescue the name of your family or go down in history as one of the greatest criminals of all time. Speaker 1 responds: Thank you very much, professor Bhakti. You continue to be an inspiration both scientifically and ethically for all of us.

Quan et al demonstrated that the introduction of DNA into a cell, even without integration, can trigger the oncogenic cGAS-STING pathway. The speaker claims that the presence of an SV40 origin of replication, a mammalian origin, in a vaccine grown in E. coli is reckless because it allows the plasmid DNA to replicate episomally in the host. The speaker alleges evidence suggests Pfizer, unlike Moderna, may have included this origin of replication due to carelessness. The speaker highlights concerns about nucleic acid persistence, noting that RT-PCR methods used in studies like Krausson and Rolchen may have amplified both DNA and RNA. The speaker suggests that prior studies assumed detected nucleic acids were RNA, but that further investigation using primers specific to the plasmid backbone might reveal the presence of residual plasmid DNA. The Krausson paper found nucleic acids present for thirty days in heart tissues, and the Rolchen paper found them for sixty days.

Every day, just the 1% of the cells of your DNA that gets replicated stretches from here to the sun four times. If you're to line it up end by end, that's very hard to conceptualize. But it should give you a little bit of humility before you go and start monkeying with it with these vaccines that can actually alter your DNA. And that's what I'm gonna show you. Is that the vaccines had a DNA contamination in them that didn't tell you about that could in fact alter your genome. Alright? These people are vibe coding your genome. And this is a major attack surface to the human gene pool because if this thing starts to alter the lifespan of people, it's going to part you with your Bitcoin. You're gonna end up spending money in a fiat system that has no controls, has no liability, and ends up oftentimes inducing mandates to get what it wants done. Many people had have peer have gone and replicated this work. It happened on Twitter. It did not happen very quickly in the peer review system. The peer review system kinda kicked it out. Some of these papers have now been peer reviewed, but it took years for them to come to this conclusion. Now, the FDA, the EMA and the TGA have all admitted that this mistake has happened. How did it happen? There's a big bait and switch. Pfizer actually ran the trial of 22,000 people on the process on the left and after they got to the trial, they then switched to the process on the right and didn't retrial the drug. And in doing so, they left a tremendous amount of excess DNA behind in the product. So all of the vaccine efficiency numbers you've heard in the news are flawed. They're not real because that's not what actually went into the trial. What went to the public was actually something that came out of this process too. It's published now in the BMJ that this fraud happened and no one has yet been prosecuted for it. So what did they leave in there? What they left in there was something we know from the polio scandal. If you're not familiar with the polio scandal, that polio vaccines were also contaminated with something known as SV40 and it created a massive cancer wave. Now the whole virus isn't in these vaccines, but there is a very curious part of this called the SV40 region that Pfizer intentionally removed from the disclosure that they gave to the FDA. So the FDA has admitted that this SV40 material is in there. They did not spell this out to the regulators. The regulators did not find them and they're actually running cover for them saying this DNA is too little consequence to matter, it's too small, and it's not functional. But we know it's functional because Dean et al has published that this piece of DNA drives DNA straight to the nucleus. It gets used in gene therapy vectors.

Speaker 0: I read the sequence and it's high-resolution. Speaker 1: It may seem low at first, but it's understandable. Speaker 0: This is written in a loop. Speaker 1: This is the genetic sequence of the spike protein. The issue is that the model RNA has a sequence that surprised me. We need to design it a bit. It contains part of the sequence SB4T, which is necessary for gene expression. The problem is that it is found in a virus that has negative effects. Also, there is another problem with this sequence. The DNA that has been transferred so far becomes more susceptible to mutation. It's a problematic point. Speaker 1: So, this SB4T sequence is also included in the promoter of this SB method, which allows it to migrate to the nucleus. Speaker 0: This is quite famous. Speaker 1: Yes, it is. The issue is that it has no relation to the process of synthesizing the messenger RNA. Speaker 0: Why did they keep the promoter sequence in the SB4T that has nothing to do with the camera's perspective in the messenger RNA synthesis process?

The SV40 component, highlighted by David Dean and others, interacts with p53, known as the "guardian of the genome," crucial for maintaining DNA integrity. The introduction of billions of these molecules raises concerns about their effects, especially since they bind to p53. Research from the Brown Cancer Institute suggests that the spike protein may alter p53 transcription, potentially leading to cancer if p53 is compromised. Damaged DNA fragments can trigger the cGAS-STING pathway, signaling danger within cells and potentially leading to oncogenesis. There is skepticism about whether this DNA enters the nucleus, but even its presence in the cytosol can be harmful. Observations of rare cancers in vaccinated children, particularly blood cancers like lymphoma, raise alarms about these potential risks.

The presence of DNA plasmids and undisclosed proteins in the Pfizer COVID-19 vaccine has raised concerns. The DNA plasmids, originating from E. Coli, were not properly removed during manufacturing, resulting in contamination. Additionally, two proteins from the simian virus 40 (SV40) were found in the vaccine, which is associated with certain cancers. SV40 was present in polio vaccines administered to millions of Americans in the past. Injecting these proteins and DNA into the body can potentially lead to mutations and increased risk of cancer. This discovery suggests a higher chance of mutation from the Pfizer COVID-19 vaccine.

When COVID-19 vaccines were sequenced, commercial annotation software highlighted functional parts of the plasmids, including antibiotic resistance genes and SV40 components. The speaker claims that Pfizer had to manually remove these annotations before submitting the plasmid map to regulators. According to the speaker, regulators received the DNA sequence, but the sponsor is obligated to annotate every open reading frame and promoter, even if their function is unknown. The speaker alleges that Pfizer intentionally removed annotations, hiding them from the FDA, which the speaker believes is a violation of guidelines. The speaker suggests the reason for hiding SV40 components is due to SV40 virus contamination in polio vaccines and its debated link to cancer. The speaker asserts that while epidemiological data is confounded by vaccine shedding, laboratory studies show SV40 is a potent oncogenic virus. The speaker claims that the vaccines contain some of the more carcinogenic components of that virus, and that these sequences are functional and have consequences.

The spike protein may inhibit tumor suppressor genes like MHS 3p53 and BRCA2, potentially leading to cancer. The mRNA vaccine contains a base that allows the spike protein to be produced for longer, possibly further inhibiting tumor suppressor genes. Concerns are raised about the long-term effects of these vaccines, with a call for them to be banned for general use and reserved for gene therapy in advanced cancer cases.

COVID-19 vaccines, especially mRNA ones, may promote cancer through impairing DNA repair, inhibiting tumor suppressor systems like p53 and BRCA, and containing DNA impurities. These impurities include fragments from circular DNA used in the manufacturing process, such as SV40, a known proto-oncogene activator. The vaccines could potentially initiate or accelerate cancer growth by weakening natural tumor surveillance systems. This phenomenon is referred to as "turbo cancer."

Strayer et al. have papers showing that SV40 plasmids are known to integrate, which is why they are used in gene therapy. There is a lot of literature from this laboratory on SV40 plasmids and integration frequency. This raises concerns that residual DNA can find its way into the nucleus.

In this video, the speakers discuss the omission of the SV40 promoter sequence in the plasmid used in vaccines. They highlight that the plasmid was annotated with various details except for the SV40 region, which is active in a million cells. Health Canada stated that sponsors should identify any biologically functional DNA, such as the SV40 enhancer, during submission. However, Pfizer did not specifically identify the SV40 sequence. The speakers explain that the plasmid map provided by Pfizer did not include annotations for the SV40 region or the F1 origin. They speculate that this omission was intentional and not a simple oversight. The speakers also mention the use of SnapGene software for plasmid annotation.

Pfizer's use of the RiboGreen technique to measure DNA in their vaccines has raised concerns about deceptive practices. The presence of billions of DNA fragments in each dose, some of which are small and more likely to integrate into the genome, is worrying. Preliminary data suggests a correlation between adverse events and contaminated Pfizer vaccines, but more research is needed. The DNA in the vaccines is different from previous contamination and carries a higher risk of integration. The FDA acknowledges the integration risk and the need for lower limits on DNA when copy numbers are high. The DNA is encapsulated in lipid nanoparticles, making it prothrombotic and potentially oncogenic. The presence of endotoxin and the spike protein in the vaccines further complicates the situation. The vaccines have been found in various tissues and can lead to prolonged expression of the spike protein. Insertional mutagenesis and cancer risk are concerns, especially for individuals with weakened immune systems. Regulatory bodies have confirmed the presence of the SV40 sequence in the vaccines, but the clinical implications are still unclear.

The initial regulatory response claimed the DNA fragment was too small to matter, but this was based on an assumption without measurement. The quantity of DNA is now shown to be over the limit, especially considering lipid nanoparticles, even if the limit were justifiable. Claims that the DNA is non-functional are also incorrect. The DNA sequence includes the SV40 promoter and enhancer region, as well as an SV40 origin of replication.

We were surprised by the findings from a patient vaccinated four times with Pfizer. A year post-vaccination, tumors developed, and the patient died within a month. Biopsies revealed SV40 in the vaccine's origin of replication. Preliminary sequencing confirmed the presence of the Pfizer vaccine's DNA, including sequences from Spike protein. Unexpectedly, the DNA copy number in the tumors exceeded that of the human genome, indicating a significant insertional mutagenesis event. Instead of the anticipated lower mutation rates, our PCR results showed signals as strong as the original vaccine vial, suggesting the DNA is replicating within the patient. This indicates that the mammalian origin of replication in Pfizer's vaccine is active in human tumors.

A colon biopsy from a Pfizer-vaccinated individual who died a month after tumor emergence revealed SV40 in the origin of replication from the Pfizer vaccine. Preliminary sequencing suggests the presence of Pfizer's vaccine. The vaccine DNA copy number was greater than the human genome, indicating replication. PCR signals suggest the vaccine concentration is similar to or higher than the original vial, despite dilution in the body. This indicates the mammalian origin of replication in Pfizer's vaccine is active in human tumors. This finding may explain shedding, which is not supposed to occur because the COVID vaccine is not intended to alter DNA. However, evidence suggests that the vaccine may be altering DNA, making it a VGBT (genome altering) product. This could mean that spike proteins are continually created, and shedding is real.

Health Canada initially claimed the Pfizer vaccine did not contain SV40, but later acknowledged its presence, stating it has no functional role. Despite this, they sought clarification from Pfizer about the residual fragments. When asked for information, Health Canada provided redacted documents, raising questions about transparency. A technique called fluorometry, which labels DNA with fluorescent markers, revealed that some RNA vaccines, particularly Moderna's, could contain up to 10 trillion copies of DNA fragments per dose. This is concerning because just 3 to 10 copies can facilitate the incorporation of SV40 DNA into a cell's nuclear genome, potentially leading to mutations associated with cancer.

A peer-reviewed paper confirms Pfizer's mRNA vaccine is contaminated with DNA and SV40 enhancers, considered dangerous. Pfizer used bacterial plasma DNA during mass production, leading to contamination with spike protein genes, antibiotic resistance markers, and SV40 enhancers. Researchers found 4-5 times more DNA than the safe limit. The DNA fragments could integrate into the human genome due to the SV40 enhancer. Injected vaccine samples caused super strong kidney cells to produce spike protein, excreted via exosomes, potentially spreading body-wide. The vaccines were toxic to these cells, causing pathological changes. The DNA, tucked into lipid nanoparticles, could integrate into the human genome, turning the jab into accidental gene therapy. The SV40 enhancer drags DNA into the nucleus. The study suggests the inclusion of SV40 enhancers was deliberate, not accidental, and scrubbed from regulatory paperwork. Experts theorize this contamination could be linked to an explosion of turbo cancers. The study concludes mRNA shots should be suspended until safety is determined. Another study found vaccine spike protein expressed in cerebral arteries of stroke patients for up to 17 months, accompanied by an autoimmune response.

The speaker states they found four pieces of the virus, not the whole virus. The pieces found include the SV40 origin of replication, the SV40 promoter, the SV40 enhancer, and part of the poly A signal. The speaker claims David Dean published that the SV40 enhancer is a nuclear targeting sequence. Therefore, claims that it will not reach the nucleus are inaccurate. The speaker asserts the presence of the SV40 origin of replication, a mammalian origin of replication, means it will replicate inside mammalian cells. The speaker believes regulators need to consider this risk.

A peer-reviewed paper confirms Pfizer's mRNA vaccine is contaminated with dangerous DNA and SV40 enhancers. During production, bacterial plasmid DNA led to contamination with spike protein genes, antibiotic resistance markers, and SV40 enhancers. Researchers found four to five times more DNA than the safe limit; these DNA fragments could integrate into the human genome due to the SV40 enhancer. Experiments showed the vaccines were toxic to cells, causing pathological changes and spike protein production, potentially spreading body-wide via exosomes. The DNA contamination, tucked into lipid nanoparticles, could lead to unintended gene therapy. The SV40 enhancer, deliberately added but removed from regulatory paperwork, raises questions about Pfizer's intentions. Experts theorize this contamination could be linked to an increase in "turbo cancers," coinciding with Pfizer's acquisition of a cancer drugmaker. An epidemiologist noted the study found DNA from the manufacturing process way over regulatory limits, including the cancer-promoting SV40 promoter enhancer and spike-producing DNA. A separate study found vaccine spike protein expressed in cerebral arteries of stroke patients for up to seventeen months, potentially contributing to autoimmune responses. There are now 11 independent reports that have found, DNA contamination within these shots of up to 60000% above regulatory limits.

Lipid nanoparticles (LNPs) can deliver mRNA and DNA to various cells, potentially leading to cancer by promoting the spread of existing cancer cells and possibly having oncogenic effects. The SV40 promoter in plasmids can amplify cancer genes, and the spike protein may inhibit tumor suppressor p53. Insertional mutagenesis can create aberrant proteins linked to cancer. mRNA can reverse transcribe to DNA and integrate into the genome, especially in ovaries and testes. Immunosuppression of T cells can allow cancer expansion. Genetic vaccines might be passed to offspring through sperm or ova, raising concerns about contaminating the gene pool. There is a lack of investigation into whether these genetic elements integrate into germ cells, which could lead to cancer through genomic integration rather than functional integration.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The video discusses the presence of SV40 (simian virus 40) in COVID genetic vaccines and its potential link to cancer. The speaker clarifies that while the vaccines do not contain the entire virus, they do contain the promoter and enhancer from SV40, which could increase the risk of DNA integration and potential oncogenesis. The speaker also mentions the role of lipid nanoparticles in vaccine delivery and the need for further research on their toxicity. Additionally, concerns are raised about the biodistribution of the vaccines and their potential impact on the germline. The speaker emphasizes the importance of understanding these risks and considering alternative approaches to respiratory virus vaccination.

The SV40 sequence in the vaccine was undeclared and raises cancer concerns because any DNA sequence that instructs cells to replicate carries a hypothetical risk of causing unregulated cell growth, which is cancer. It is claimed that cancers appearing post-vaccination should be sequenced and studied to determine if the SV40 sequence is causing them. This sequencing and study has not yet occurred, and is a critical step in understanding the potential link between the vaccine and cancer.